CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) MODELS H135 H170 H175 H177 AND H179
A Cardiac Resynchronization Therapy Defibrillator (CRT-D) Related Image
(Not Necessarily related to the device)Description:
CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) MODELS H135, H170, H175, H177, AND H179 by Boston Scientific Corp.
The CONTAK RENEWAL Cardiac Resynchronization Therapy Defibrillator (CRT-D) is a state-of-the-art therapeutic system designed to provide electrical stimulation to the heart in patients with heart failure and to monitor and correct life-threatening cardiac arrhythmias. Made by Boston Scientific Corp., a global leader in medical technologies, the device is offered in several models to suit the individual needs of patients - H135, H170, H175, H177, and H179.
This pioneering multifunctional device combines the distinctive capabilities of a pacemaker and an implantable defibrillator. Its primary use is to slow down fast or irregular heart rhythms, to speed up slow heart rhythms, and to aid the heart chambers to beat in a more coordinated way - a benefit most essential for patients suffering from heart failure. With Cardiac Resynchronization Therapy (CRT), the device improves the efficiency of the heart, offers symptom management, and enhances the quality of life.
Moreover, the CONTAK RENEWAL CRT-D is designed with advanced monitoring features. It vigilantly tracks the heart rhythm and, in the case of a life-threatening arrhythmia, delivers a shock therapy to restore normal heart rhythm. It is thereby capable of preventing sudden cardiac death, providing patients with an extra layer of security and peace of mind.
With its cutting-edge technology, reliability, and patient-centered benefits, the CONTAK RENEWAL CRT-D offers a comprehensive solution for patients with heart failure and arrhythmia, contributing to better patient outcomes and promoting a healthier, more active lifestyle.
Primary Use:
Primary Medical Use of CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) MODELS H135 H170 H175 H177 AND H179
The CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) MODELS H135, H170, H175, H177, AND H179 in the category of Pacemakers, are sophisticated medical devices proficiently tailored to meet the primary medical use of coordinating and regulating the heart's contractions. The primary focus of these models is to provide therapeutic solutions for conditions like Heart Failure (HF) and lethal arrhythmias. Patients who are diagnosed with such conditions exhibit a common issue: an irregular or uncoordinated heartbeat.Performing an Essential Role in Cardiac Resynchronization
The models H135, H170, H175, H177, aHow It Works:
Understanding the CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) MODELS H135 H170 H175 H177 AND H179
The CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) models H135, H170, H175, H177, and H179 are advanced medical devices utilized primarily for cardiac resynchronization therapy. They belong to the category of Pacemakers due to their essential function in maintaining a normal heart rhythm. These devices are designed to help manage congestive heart failure and other associated arrhythmias. They achieve this by optimizing the coordination of the heart's contractions, promoting effective blood circulation throughout the body, thereby intrinsically improving a patient's overall quality of life and potentially prolonging it.Functionality of CRT-D Models H135, H170, H175, H177, and H179
The core function of these cutting-edge devices revolves around providing cardiac resynchronization therapy along with defibrillation capabilities. Through this combination, the devices enhance the heart's efficiency while concurrently providing a necessary safeguard against potentially lethal heart rhythms. In particular, the devices work by sending precisely timed electrical impulses to the heart's lower chambers (the ventricles), assuring synchronized contractions and thereby improving heart function.Integration with Defibrillator Capabilities
With cardiac resynchronization alone, patients would still be susceptible to serious arrhythmias such as ventricular tachycardia or ventricular fibrillation. Therefore, the inclusion of defibrillator function in the device provides an automatic response to these lethal conditions, delivering an electrical shock to the heart to re-establish normal rhythm.Installation Position
CRT-D devices are typically implanted under the skin below the collarbone, similar to standard pacemakers. Wires, referred to as leads, are threaded through veins into the heart, connecting the device to the organ and enabling the synchronized electrical impulses that help control heart rhythm. In conclusion, the CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) models H135, H170, H175, H177, and H179 represent a significant advancement in cardiac care, embodying the harmonious fusion of pacing and defibrillation technologies. They are reliable assets in a physician's toolset, offering a life-changing treatment option for patients suffering from arrhythmias and heart failure.Manufacturer:
Boston Scientific Corp.
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.